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Abstract 
Background : To assess the prognostic 
stratification of prostatic cancer according to 
modified Gleason Grading System 
Methods: In this observational study 65 patients 
having prostatic carcinoma, who underwent  
prostatectomy by different surgical procedures were 
included. Lab request forms and histopathology 
reports of these patients were reviewed for 
prognostic grade groups. Gleason grade ≤6; 3 + 4; 4 + 
3; 8 and 9–10 were assigned by two histopathologists 
separately to each prostatic cancer in addition to 
already assigned Gleason grades. 
Results: Sixty five patients were found to be 
diagnosed with prostatic carcinoma. Age ranged 
from 64-85 years. Eight patients were found 
incidentally to have prostatic cancer in T1 stage with 
six having grade group I cancer, one with grade 
group II and the one with a grade group III cancer. 
The remaining 57 cases were already diagnosed 
before surgery by different diagnostic tests. Out of 
these 57 cases 15 had Gleason grade 7 cancer (7 with 
grade group II and 8 with grade group III), 18 had 
Gleason grade 8 (All with grade group IV) and 24 
cases had combined Gleason grade 9 and 10 cancer 
(All with grade group V). Cancer of all of these 57 
cases was beyond T1 stage. Thirty cases were in 
stage T2, 20 in stage T3 and only 7 in stageT4.  
Conclusion: While retaining the essence of the 
conventional Gleason system, the 2014 modified 
system of grade groups categorize patients of 
prostatic carcinoma, prognostically with more 
accuracy acceptable to both clinicians and patients. 
Key Words: Prognostic Stratification , Prostatic 
Cancer, Modified Gleason Grading System 
Introduction 
Prostate cancer (PCa) is the second most commonly 
diagnosed cancer and 6th leading cause of death due 
to cancer in males through out the world.1 There are 
several diagnostic tools including serum PSA, DRE 
and imaging modalities like transrectal 
ultrasonography which are helpful in picking of this 
cancer before prostatectomy, but it is the 
histopathology of biopsy specimens that is considered 
to be the gold standard.2,3  
To evaluate prostate cancer in prostatectomy 
specimens a grading system based on its histological 
architecture was developed by Donald Gleason in 1966 
and is considered a strong predictor of prognosis since 
the time of its inception.4,5,6 In this system grade is the 
sum of two most common (primary or predominant + 
Secondary or second most common) grade patterns 
and is reported as Gleason score.5 To avoid ambiguity 
Gleason score is reported in the form of a 
mathematical equation i.e. Gleason score 3+4=7.7 
Synonyms for Gleason score are Gleason sum or 
combined Gleason grade.5 Both the primary and the 
secondary architectural patterns are identified and 
assigned a number from 1 to 5. Pattern-1 is considered 
as the most differentiated while pattern 5 the least 
differentiated one. When a carcinoma has one 
histologic pattern instead of two then same number is 
assigned to both primary and secondary patterns and 
is added. Range wise Gleason scores range from 2 
(1+1=2) to 10 (5+5=10). Grade 2 tumors are composed 
uniformly of Gleason pattern-1 and are most 
differentiated while Gleason score 10 are uniformly 
composed of Gleason pattern-5 and are the most 
undifferentiated tumors5. With changing pathological 
and clinical practice, several controversial areas were 
found in this system.8 More than 30 % cases of prostate 
cancer comprised of pattern 1 and 2 in the original 
publications by Gleason which are presently not 
reported on biopsy specimens. Reporting of multiple 
prostatic cores and radical prostatectomy specimens 
having tertiary pattern were also not described by the 
initial scoring system. Similarly a minor component of 
high grade cancer, if present was not reported in this 
initial system. 6,8  
To address these and many unmentioned issues an 
International Society of Urological Pathology (ISUP) 
arranged consensus conferences in 2005 in San 
Antonio, Texas (USA) and subsequently in 2014 in 
Chicago (USA). In 2005 conference only pathologists 
participated while in 2014 conference urologists, 
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pathologists, radiation therapists and oncologists 
participated. They agreed on developing a system of 
prognostic grade groups from I-V to be used in 
conjunction with original Gleason grades. They 
incorporated Gleason scores into this new system of 
grade groups (Table 1).6,7,9,10,11-13  
Table 1: Modified Gleason Scoring for 
 prostatic cancer 
Gleason pattern Gleason score Grade 
Group 
Gleason Patterns 
1-3                
(Distinct and discrete 
  individual glands) 
Gleason score ≤ 6        
    
Gleason score 3+4=7  
       
Gleason score 4+3=7  









fused or poorly 
formed glands) 
Gleason score 4+4=8 
Gleason score 3+5=8 





5 (cords,  
solid nest, sheets, 
single cells. 
comedo necrosis)  
                 
Gleason score 4+5=9 
Gleason score 5+4=9 





Gleason score 6 cancer, managed presently by active 
surveillance is perceived by patients as more ominous 
than grade group 1 cancer and in the same way over-
treated sometimes by the oncologists. Patients feel 
uneasy with this grade 6 cancer and suffer usually 
from psychological problems like depression and 
inclination towards suicide.9 On the contrary, grade 
group 1 cancer out of 5 in the recent modified system 
sounds more indolent as compared to Gleason grade 6 
cancer out of 10 in the previous system.4. Previously 
Gleason grade 3+4=7 and 4+3= 7 tumours were 
considered to have the same gravity of aggressiveness 
regarding stage and biochemical recurrence. In the 
recent grade group system, grade groups-II and III are 
assigned to Gleason grade 3+4=7 and 4+3= 7 tumors 
respectively as grade 4+3=7 cancer is more aggressive 
compared to grade 3+4=7 and vice versa. Similarly all 
cribriform patterns, fused glands, poorly formed 
glands and glomeruloid morphology were considered 
Gleason pattern 4 instead of 3 in the modified system 
for the purpose of simplicity and interobserver 
reproducibility.4,7This new grade group system is 
incorporated into the recent 2016 edition of WHO 
classification of prostatic tumors due to its simplicity, 
provision of accurate prognostic stratification and 
reflection of prostate cancer biology more accurately as 
compared to original system of Gleason score. 6, 7,10 12     
Patients and Methods 
In this observational study all the patients were having 
prostatic carcinoma and operated at LRH or elsewhere 
by any surgical method. Patient having inadequate or 
autolysed specimens in spite of having presurgically 
diagnosed prostatic cancer by serum prostate specific 
antigen (PSA), digital rectal examination (DRE) or 
transrectal ultra-sonography were excluded from the 
study.Slides patients (n=65) were examined by two 
histopathologists for assigning recently adopted grade 
groups to the already diagnosed prostatic cancers with 
allocated old Gleason scores. If there was no consensus 
between the pathologists or there was some ambiguity 
regarding the pattern of cancer, then deep sections or 
serial sections were taken of their respective blocks, 
processed and stained as per standard protocol 
followed in the department. New grade groups were 
assigned to all the cases and arranged in parallel to the 
previously assigned Gleason scores. Data obtained 
from evaluation by both old and new systems was 
arranged in a tabulated form to compare the simplicity 
and applicability of both the systems. Gleason score = 
7 cancers were also divided into two different 
prognostic grade groups. Data thus collected was 
analyzed by Microsoft excel software. 
Results 
Sixty five patients having age of 64–85 years (mean = 
74 years) were found from the record of the laboratory 
to have prostatic carcinoma. They were operated by 
different surgical procedures. Eight cases were found 
incidentally to have prostatic cancer while evaluating 
their prostatic chips removed by transurethral 
resection of prostate (TURP) for the treatment of 
benign prostatic hyperplasia (BPH) without any 
presurgical knowledge of cancer in them. The 
remaining 57 cases were diagnosed presurgically by 
various diagnostic methods like DRE, serum PSA level 
estimation, transrectal ultrasound etc. All of these 57 
cases were subjected to radical prostatectomy being a 
planned treatment option for their health problem..All 
the patients either diagnosed incidentally in the TURP 
specimens or diagnosed presurgically for prostatic 
cancer were having age above 60 years (Table 2) 
 
Table 2:Age wise distribution of patients (n=65) 




Journal of Rawalpindi Medical College (JRMC); 2016;20(4):281-284 
 283 
Pattern 3 (Fig. I), 4 (Fig. II) and 5 (Fig. III) were the 
patterns commonly observed in our study. Pattern 2 
(Fig. IV) was also observed but in less percentage not 
qualifying for primary or secondary pattern in any 
case to be recorded in grading of the tumor. No case of 
pattern 1 was observed in this study. As per old 
system of Gleason scoring six out of the eight 
incidentally found cancers were assigned Gleason 
score 6 with all having 3+3=6 grade while two had 
score of 7 with one having 3+4=7 grade and the other 
having 4+3=7 grade. According to recent ISUP 2014 
system of grade groups the six cases having prostatic 
carcinoma of grade 3+3=6 were kept in grade group I. 
The one having Gleason grade 3+4=7 cancer was kept 
in grade group II while the other having grade 4+3=7 
cancer was kept in grade group III. Out of these eight 
specimens, six had a tumor volume of less than 5% of 
the total resected chips (T1a cancer) while two had a 
tumor volume of more than 5% of the total resected 
specimens (T1b cancer).Out of the remaining 57 cases 
of prostatic cancer 15 cases had Gleason grade 7 cancer 
according to old Gleason score, 18 had grade 8 cancer 
while 11 and 13 cases had Gleason grade 9 and 10 
cancer respectively. No Gleason grade 6 cancer was 
found in these 57 prostatectomy specimens. During 
microscopic evaluation, according to ISUP 2014 system 
seven cases were kept in grade group II and eight 
cases were given grade group III out of 15 cases 
already diagnosed with Gleason grade 7 cancer. As 
per recommendations of new grading system all 18 
cases of Gleason grade 8 cancer were accommodated 
in grade group IV cancer while 24 cases of combined 
Gleason grade 9 and 10 cancers were kept in grade 
group V (Table-3). All of these cancers were beyond T1 
stage. Thirty cases were in stage T2, 20 in stage T3 and 
seven in stage T4. Nodal (N) status of all these cases 
except the last 7 cases was N0. Seven cases of stage T4 
had N1 status. There was no distant metastasis (M0) in 
all the 65 cases of prostate cancer. 
Table 3:Distribution of prostatic cancer according to 
modified grade group system. (n=57) 
Gleason Grade Grade 
groups 
Number of prostatic 
cancer 
3+4=7 II 7 
4+3=8 III 8 
4+4=8 IV 5 
3+5=8 IV 7 
3+5=8 IV 6 
4+5=9 V 9 
5+4=9 V 11 
 5+5=10 V 4 




















This was an easy practice to assign grade groups to 
prostate cancer as per modified ISUP system while 
Figure 1. Prostatic Cancer – 
Pattern 3 
 
Figure 4. Prostatic 
cancer- Pattern 2 
 




- Pattern 4 
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evaluating it microscopically, in place of giving 
Gleason patterns and grades to them. As Gleason 
grading system is in practice for last 50 years and has 
gained vast acceptability, therefore the present system 
should be used in conjunction with it and grade group 
of each prostate cancer should be written in bracket 
along with the Gleason grade as accepted by the WHO 
for 2016 classification of prostatic tumors.7 We have 
also adopted this 2016 WHO criteria in the present 
study. In the previous system, Gleason grade 6 
prostatic cancer, although considered an indolent 
cancer by the pathologists and oncologists, is taken 
worrisome by the patients. The figure of 6 being amid 
of 2 and 10 is perceived by a patient to be of an 
intermediate severity instead of low one and thus puts 
a lot of psychological burden on his mind.9 In the 
modified system of grade groups if the same patient is 
told that he has grade group-1 prostate cancer than it 
is easy to convince him about the indolent behavior of 
his tumor and easy to alleviate his anxiety.4 These 
Grade Groups predict progression of prostatic 
carcinoma more accurately as compared to 
conventional Gleason risk stratification groups (≤6 or 
low risk, 7 or intermediate risk and 8–10 or high risk).6 
Several studies have been conducted about merits and 
demerits of this modified system of grade groups for 
prognostic stratification of prostatic carcinoma. 6,7,10,14,15 
All of them have concluded that this system is simple 
and applicable being based on the already prevalent 
Gleason grading system. The present study has also 
shown simplicity and applicability of the modified 
system without facing any difficulty .  
 
Conclusion 
1.The modified grade group system of prostate cancer 
is simple and offers an excellent 5-tiered prognostic 
stratification of this carcinoma.  
2. Modified grade group system in conjunction wit 
conventional Gleason scoring system can improve the 
applicability  in prognostic scoring of CA prostate. 
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